Zai Lab Ltd, 2026-11-09
A new SEC Form D private-offering notice from Cambridge, MA, a $249,933,600 filer-stated offering target in Biotech. The source filing is one click away.
What this filing says
Commercial stage biopharmaceutical company developing and marketing therapies in oncology, immunology, neuroscience and infectious disease, publicly traded on Nasdaq as ZLAB
This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.
Other Form D filings from the same week
each with its own page and its own EDGAR source- Flip Flow HQ Inc, 2026-11-09, $200K, Brighton, MA
- InSitu Biologics, Inc., 2026-11-10, $19.8M, Oakdale, MN
- Accelerate, LLC, 2026-11-09, $500K, Milford, MA
- ABVC BIOPHARMA, INC., 2026-11-10, $3.4M, Fremont, CA
- Newton Research, Inc., 2026-11-09, $30M, Needham, MA
- NBO Pharma Inc., 2026-11-09, $7M, Bedford, NY
The Monday digest, free
A summary of who raised money last week: the ones worth a call first, then every company that filed, by state and sector. One email, Monday mornings. No spam, unsubscribe anytime.
By subscribing you agree to our Terms and Privacy Policy.